IN201841011100A - - Google Patents
Download PDFInfo
- Publication number
- IN201841011100A IN201841011100A IN201841011100A IN201841011100A IN201841011100A IN 201841011100 A IN201841011100 A IN 201841011100A IN 201841011100 A IN201841011100 A IN 201841011100A IN 201841011100 A IN201841011100 A IN 201841011100A IN 201841011100 A IN201841011100 A IN 201841011100A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201841011100A IN201841011100A (enExample) | 2018-03-26 | 2018-03-26 | |
| US16/103,615 US11020351B2 (en) | 2018-03-26 | 2018-08-14 | Stable bilayer tablet compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201841011100A IN201841011100A (enExample) | 2018-03-26 | 2018-03-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN201841011100A true IN201841011100A (enExample) | 2019-09-27 |
Family
ID=67984528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN201841011100A IN201841011100A (enExample) | 2018-03-26 | 2018-03-26 |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US11020351B2 (enExample) |
| IN (1) | IN201841011100A (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4076402A1 (en) * | 2019-12-19 | 2022-10-26 | KRKA, d.d., Novo mesto | Dosage form comprising amorphous solid solution of empagliflozin with polymer |
| US20250082641A1 (en) * | 2021-07-26 | 2025-03-13 | Unison Pharmaceuticals Pvt. Ltd. | A pharmaceutical composition comprising combination of sglt2 inhibitor and dpp-iv inhibitor |
| EP4415723A4 (en) | 2021-10-12 | 2025-09-03 | Unison Pharmaceuticals Pvt Ltd | PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF SITAGLIPTIN AND EMPAGLIFLOZIN |
| TR2021021295A2 (tr) * | 2021-12-28 | 2023-07-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Sicak eri̇yi̇k ekstrüzyon i̇le hazirlanan empagli̇flozi̇n ve li̇nagli̇pti̇n i̇çeren bi̇r farmasöti̇k kompozi̇syon |
| EP4456901A4 (en) * | 2021-12-28 | 2025-12-10 | Sanovel Ilac Sanayi Ve Ticaret As | Pharmaceutical composition of empagliflozin and linagliptin processed by hot extrusion |
| TR2022007542A2 (tr) * | 2022-05-09 | 2022-05-23 | Atabay Kimya Sanayive Tic A S | Li̇nagli̇pti̇n i̇çeren fi̇lm kapli tablet |
| EP4299054A1 (en) * | 2022-06-29 | 2024-01-03 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A tablet comprising empagliflozin |
| CN115227661B (zh) * | 2022-09-22 | 2022-12-13 | 北京惠之衡生物科技有限公司 | 一种利格列汀片及其制备方法 |
| EP4385501A1 (en) * | 2022-12-15 | 2024-06-19 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A pharmaceutical formulation comprising linagliptin, pioglitazone and a sglt-2 inhibitor |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9572784B2 (en) * | 2011-01-07 | 2017-02-21 | Elcelyx Therapeutics, Inc. | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
| US20160000816A1 (en) * | 2013-04-05 | 2016-01-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| US9988367B2 (en) * | 2016-05-03 | 2018-06-05 | Bayer Pharma Aktiengesellschaft | Amide-substituted pyridinyltriazole derivatives and uses thereof |
-
2018
- 2018-03-26 IN IN201841011100A patent/IN201841011100A/en unknown
- 2018-08-14 US US16/103,615 patent/US11020351B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11020351B2 (en) | 2021-06-01 |
| US20190290588A1 (en) | 2019-09-26 |